Your browser doesn't support javascript.
loading
Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth.
Chen, Jun; Kinoshita, Taisei; Sukbuntherng, Juthamas; Chang, Betty Y; Elias, Laurence.
Afiliação
  • Chen J; Research Department, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California.
  • Kinoshita T; Research Department, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California.
  • Sukbuntherng J; Clinical Pharmacology and DMPK Department, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California.
  • Chang BY; Research Department, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California. bchang@pcyc.com.
  • Elias L; Research Department, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California.
Mol Cancer Ther ; 15(12): 2835-2844, 2016 12.
Article em En | MEDLINE | ID: mdl-27678331
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Receptor ErbB-2 / Inibidores de Proteínas Quinases / Receptores ErbB / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Receptor ErbB-2 / Inibidores de Proteínas Quinases / Receptores ErbB / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2016 Tipo de documento: Article